Filter
1082
Filtered Results: 1082
Text search:
isoniacida
Featured
Recommendations
116
New Publications
284
Language
Document type
No document type
791
Guidelines
117
Studies & Reports
69
Manuals
45
Strategic & Response Plan
20
Training Material
17
Fact sheets
14
Situation Updates
5
Infographics
4
Countries / Regions
Western and Central Europe
49
India
37
Kenya
35
South Africa
29
Nepal
28
Tanzania
28
Eastern Europe
27
Uganda
24
Latin America and the Carribbean
20
Nigeria
19
Namibia
18
Ethiopia
18
Zambia
18
Malawi
17
Peru
15
Argentina
15
Rwanda
14
Germany
14
Bangladesh
14
Cambodia
13
Colombia
12
Asia
12
Brazil
12
El Salvador
11
Mozambique
11
Ukraine
10
Bolivia
10
Paraguay
9
Botswana
9
Indonesia
9
Myanmar / Burma
9
Lesotho
8
Ghana
7
Zimbabwe
7
South–East Asia Region
7
Russia
7
Eswatini/ Swaziland
7
Philippines
5
Global
5
Africa
5
Ecuador
5
Benin
4
Sierra Leone
4
Chile
4
Liberia
4
Tajikistan
3
Georgia
3
Bhutan
3
Timor Leste/ East Timor
2
Haiti
2
Venezuela
2
Uruguay
2
Sri Lanka
2
Pakistan
2
North Korea
1
Switzerland
1
Gambia
1
Cameroon
1
Albania
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Malaysia
1
Armenia
1
Dominican Republic
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Turkmenistan
1
East and Southern Africa
1
Vietnam
1
Papua New Guinea
1
Angola
1
Libya
1
South Sudan
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
294
TB
81
Studies & Reports
56
Drugs & Medical Equipment
41
Guidelines
38
Capacity Building
30
Pediatrics
21
Policies
20
HIV & STI
20
Statistics
19
Women & Child Health
17
Community Health
16
Paediatrics
12
Demograhic Health Surveys DHS
10
Disease Prevention & Control
10
Bacteriology
7
Countries
6
Clinical Training
5
Community Health
5
COVID-19
4
Clinical Guidelines
4
Information, Education and Communication (IEC)
4
Communicable Diseases
4
Public Health
3
Neonatal Care
3
Communicable Diseases
2
Dermatology
2
Humanitarian Aid
2
Monitoring & Evaluation
2
Maternal & Child Health
2
Medical Devices & Equipment
2
Quality Control & Assurance
2
Gynaecology & Obstetrics
2
Health Systems
2
NTDs & Others
2
Primary Health Care
2
Dental & Eye Care
1
Public Health
1
Under-5 nutrition
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
IEC Material
1
Virology
1
Infection Control & Prevention (IPC)
1
Vaccine-preventable Diseases
1
Training Manuals
1
Humanitarian Crisis
1
COPD/Asthma
1
Needs Assessment
1
Leprosy
1
Nutrition
1
Maternal Health
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Drug resistant TB
48
Adults
45
Detection & Diagnosis
44
Prevention & Control
41
Children
33
TB/HIV Coinfection
33
TB & Prisoners
24
Training
23
Reports & Studies
21
Children & Adolescents
19
Childhood TB
18
TB & Other Vulnerable Populations
18
Essential Medicines & Devices Lists
18
Disease Prevention & Control
16
Research & Access
16
General
15
AmR (Region of Americas)
15
Treatment & Prevention
14
Germany
14
Clinical Aspects
13
Peru
13
TB
13
Policies & Strategies
12
TB & Drug Abuse
12
Clinical Aspects, Treatment & Prevention
12
Reports
12
Other Countries
12
Eastern Europe and central Asia
12
Laboratory
11
Brazil
11
El Salvador
11
Argentina
11
HIV in Key Populations
11
Colombia
10
Policies and guidelines
10
TB/HIV Global
10
Nutrition
10
Treatment Guidelines HIV
9
IEC Materials
9
Advocacy & Communication
9
Essential Medicines
9
Epidemiology
9
Eastern Europe & Central Asia
9
Kenya
9
SEAR (South-east Asia Region)
9
Communication & Training
8
TB/HIV
8
HIV and coinfection
8
Antiretroviral Treatment ART
8
South Africa
7
Rwanda
7
HIV &TB
7
General
7
Clinical Guidelines
7
HIV service delivery
7
South-east Asia Region
7
Biosafety
6
Vaccines & Immunization
6
Ukraine
6
Asia and Pacific
6
Malawi
6
Tuberculosis
6
Uganda
6
Prisoners
6
Opportunistic Infections
5
Namibia
5
TB/COVID-19
5
Prophylactic Treatment
5
Nigeria
5
Moldova
4
Country specific
4
Pediatrics
4
Policies
4
National Policies
4
HIV
4
Prophylaxis
4
Mozambique
4
Drug resistance
4
Ethiopia
4
Universal Health Coverage UHC and 90-90-90 Strategy
4
Chile
4
Ecuador
4
Rational use of Medicine
4
Romania
4
Ghana
4
Latin America & the Carribean
4
Kazakhstan
4
ART Drug Resistance
3
HIV testing & services
3
Eastern Mediterranean Region
3
TB
3
People who injecting Drugs
3
SOPs
3
Georgia
3
Sex Worker
3
Country specific documents
3
Community Health Workers CHW
3
Falsified & Substandard
3
Model Formulary
3
Pharmacy Practice
3
Co-Morbidities (except TB)
3
Substance Use Disorders & Addiction
3
Community Worker
3
Tajikistan
3
Western & Central Europe
3
Eastern and Southern Africa
3
Behaviour Change/Life Skill Education
2
General Reports
2
Clinical Guidelines
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Others
2
Clinical aspects
2
Country Guidelines
2
Workplace
2
Russia
2
Laboratory
2
Essential List
2
Country Specific
2
Latin America
2
Overview
2
Prices and Patents
2
Pediatrics
2
Prevention & Measures
2
Clinical Aspects & Diagnostics
2
Health Worker
2
Botswana
2
Assessment
2
Testing Guidelines
2
Drugs
1
Alcohol
1
Surveillance
1
Agriculture & Veterinary
1
Azerbaijan
1
Policies & Strategies
1
HIV surveillance
1
Zambia
1
Social Worker
1
Eastern Europe
1
Global
1
Vaccination
1
Adherence
1
African Region
1
Health & Refugee
1
Discrimination & Stigma
1
Human Rights
1
Laboratory
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
Treatment Guidelines
1
Research & Development
1
Studies
1
Clinical Guidelines
1
Global Impact: Socio-economic, health services, TB & HIV
1
Camps and Camp-like Settings
1
Food and Nutrition
1
Latin America
1
Situation Reports COVID-19
1
Handbooks & Manuals
1
Midwives
1
Nurses
1
Estonia
1
Pharmacy Management
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Mental Disorders
1
Guidelines & Manuals
1
General
1
Access to treatment and laboratory
1
Armenia
1
Clinical Aspects & Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
General
1
Neurological Disorders
1
Bipolar Affective Disorders
1
Regional Reports & Guidelines, others
1
AR (African Region)
1
Lesotho
1
Stewardship
1
International
1
Others
1
Anxiety Disorders
1
Overview & Statistics
1
Reports & Studies Children HIV
1
Preparedness & Prevention
1
Unaccompanied Refugee Minors
1
Depression
1
Case Definitions
1
AMR
1
Meningitis & Encephalitis
1
Volunteers
1
Treatment & Clinical Management
1
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
The report presents the latest data on more than 50 health-related Sustainable Development Goal and "triple billion" target indicators. The 2021 edition includes preliminary estimates for global excess deaths attributable to COVID-19 for 2020 and the state of global and regional health trends from 2...
The Early Essential Newborn Care Pocket Guide was developed by the WHO Regional Office for the Western Pacific for introducing and scaling-up Early Essential Newborn Care. This step-by-step Guide is intended to provide a portable and practical summary of the up-to-date global evidence for newborn ca...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The Lancet Global Health January 24, 2022
Laboratory Safety Handbook. Global edition
Las pruebas de cultivo y sensibilidad a fármacos son necesarias especialmente para los pacientes con riesgo de tuberculosis resistente a los medicamentos y para vigilar su respuesta al tratamiento. Si bien el cultivo y las pruebas de sensibilidad son ca...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
